Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.

Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5' portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3' portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.

[1]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of immunology.

[2]  Kouhei Tsumoto,et al.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Kabasawa,et al.  HLA antigens in Japanese patients with systemic lupus erythematosus. , 1994, Scandinavian journal of rheumatology.

[4]  Jurg Ott,et al.  Handbook of Human Genetic Linkage , 1994 .

[5]  P. Vermersch,et al.  Association of multiple sclerosis with ILT6 deficiency , 2005, Genes and Immunity.

[6]  P. Gregersen,et al.  The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[7]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[8]  K. Deichmann,et al.  Common polymorphisms and alternative splicing in the ILT3 gene are not associated with atopy. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[9]  A. Ziegler,et al.  Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster , 2000, Immunogenetics.

[10]  Heather G. Shilling,et al.  Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype1 , 2002, The Journal of Immunology.

[11]  U. de Faire,et al.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. , 2004, Arthritis and rheumatism.

[12]  B S Weir,et al.  Independence tests for VNTR alleles defined as quantile bins. , 1993, American journal of human genetics.

[13]  Yusuke Nakamura,et al.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities , 2005, Nature Genetics.

[14]  D. Cosman,et al.  The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. , 2002, The American journal of pathology.

[15]  A. Nakamura,et al.  Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice , 2002, Nature Immunology.

[16]  M. Cooper,et al.  A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Nakamura,et al.  Exacerbated graft-versus-host disease in Pirb−/− mice , 2004, Nature Immunology.

[18]  Michael J. Wilson,et al.  Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 , 2002, The Journal of Immunology.

[19]  M. Petri,et al.  Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[21]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Mańczak,et al.  Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. , 2004, Human immunology.

[23]  A. West,et al.  Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.

[24]  J. Terwilliger,et al.  A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. , 2000, Journal of autoimmunity.

[25]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[26]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[27]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[28]  Michael J. Wilson,et al.  Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures1 , 2001, The Journal of Immunology.

[29]  T. Sasazuki,et al.  Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. , 2004, The Journal of investigative dermatology.

[30]  M. González-Escribano,et al.  Association of NRAMP1 promoter gene polymorphism with the susceptibility and radiological severity of rheumatoid arthritis. , 2002, Tissue antigens.

[31]  Daniel J. Schaid,et al.  Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis , 2001, The Journal of experimental medicine.

[32]  M. Colonna,et al.  Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways , 1997, European journal of immunology.

[33]  M. Ono,et al.  Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. , 1998, Journal of immunology.

[34]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[35]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[36]  K. Tokunaga,et al.  Tumor necrosis factor α 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis , 2000 .

[37]  C. Weyand,et al.  CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. , 2001, Arthritis and rheumatism.

[38]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[39]  T. Bellón,et al.  Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor1 , 2002, The Journal of Immunology.

[40]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[41]  P. Bjorkman,et al.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.

[42]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[43]  K. Tokunaga,et al.  Variations in immune response genes and their associations with multifactorial immune disorders , 2002, Immunological reviews.

[44]  B. Koeleman,et al.  KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. , 2003, Diabetes.

[45]  Masahiro Yamamura,et al.  Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.

[46]  K. Tokunaga,et al.  ROUTINE LOW AND HIGH RESOLUTION TYPING OF THE HLA‐DRB GENE USING THE PCR‐MPH (MICROTITRE PLATE HYBRIDIZATION) METHOD , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[47]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[48]  DNA sequence variation and molecular genotyping of natural killer leukocyte immunoglobulin-like receptor, LILRA3 , 2003, Immunogenetics.

[49]  M. Colonna,et al.  Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4 , 1999, Mammalian Genome.

[50]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.